Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Kropacheva ES"'
Autor:
A N Rogoza, Marina V. Kostiukevich, Panchenko Ep, Iuliia A. Iuricheva, Alexander Litvin, E. Zheleznova, I E Chazova, E M Elfimova, Madina D. Utsumueva, Sergei P. Golitsyn, Lada Iu. Laiovich, Juliya V. Zhernakova, Kropacheva Es, Nikolai Iu. Mironov
Publikováno v:
Системные гипертензии, Vol 18, Iss 3, Pp 105-128 (2021)
Arterial hypertension (AH) is a leading risk factor for cardiovascular disease as well as it is the most common, independent and potentially reversible risk factor for atrial fibrillation (AF). AH contributes to the occurrence and maintenance of AF d
Publikováno v:
Терапевтический архив, Vol 92, Iss 9, Pp 15-23 (2020)
To analyze the frequency of resumption of anticoagulant therapy (ACT) after major and clinically significant bleeding among AF patients who received oral anticoagulants and were observed in the Department of clinical problems of atherothrombosis from
Autor:
N P Mitkovskaya, A O Konradi, Komarov Al, E I Tarlovskaya, Ye V Shlyakhto, V A Snezhitskiy, S V Malchikova, A I Chesnikova, L V Kolotsey, M M Petrova, A B Sugraliyev, V V Skibitsky, A G Arutyunov, N. A. Koziolova, Ya A Orlova, Tereshchenko Sn, Kropacheva Es, G P Arutyunov, I. V. Fomin, Yu N Belenkov, Panchenko Ep, I. S. Yavelov, Ardashev Av, I I Shaposhnik, N Yu Grigorieva, G A Dzhunusbekova, S G Kanorskii, A P Rebrov, Hamayak Sisakian, E G Zhelyakov, O. M. Drapkina
Publikováno v:
Kardiologiia. 60:4-14
This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific fea
CYP2C9 and VKORC1 genotyping for the quality of long-standing warfarin treatment in Russian patients
Autor:
A. B. Dobrovolsky, Galina Lifshits, Tatyana Vavilova, Kropacheva Es, Alevtina Grontkovskaya, Titaeva Ev, Olga V. Sirotkina, Irina Galkina, Dmitry Zateyshchikov, Elizaveta Panchenko, Lyudmila Grehova, O A Zemlyanskaya, Dmitry Trofimov, Nadezda Vorobyeva, Sergey Sinitsin, Irina Zotova, Natalya Vereina
Publikováno v:
The Pharmacogenomics Journal. 20:687-694
A total of 263 warfarin naive patients with indications to long-term anticoagulation were included in prospective multicenter study and randomized into Pharmacogenetics and Standard dosing groups. The loading warfarin dose in Pharmacogenetics group w
Publikováno v:
Терапевтический архив, Vol 91, Iss 9, Pp 38-46 (2019)
To evaluate efficacy and safety of reduced dose of direct oral anticoagulants (DOACs) as part of triple antithrombotic therapy in AF patients, undergoing elective percutaneous coronary intervention (PCI), and to identify factors, associated with this
Autor:
A. B. Dobrovolsky, Elizaveta Panchenko, Anatoly Samko, Elena N. Krivosheeva, Kropacheva Es, Titaeva Ev
Publikováno v:
Circulation. 142
Introduction: Patients (pts) with AF, undergoing elective PCI, receiving multicomponent antithrombotic therapy (MAT) have high risk of stroke/systemic embolism and coronary events. There is no biochemical markers associated with negative prognosis in
Autor:
A. B. Dobrovolsky, Panchenko Ep, Kropacheva Es, V M Mironov, E N Krivosheeva, Titaeva Ev, A N Samko
Publikováno v:
Kardiologiia. 60(8)
Aim Searching for clinical, angiographic, and biochemical predictors of cardiovascular complications (CVC) and hemorrhagic complications in patients with atrial fibrillation (AF) receiving a multicomponent antithrombotic therapy (MAT) for an elective
[Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up]
Publikováno v:
Терапевтический архив, Vol 89, Iss 9, Pp 78-86 (2017)
To investigate the prognostic value of renal function and to estimate glomerular filtration rate (GFR) changes during a 5-year follow-up of patients receiving warfarin therapy.200 patients (124 men, 76 women) mainly from a group at high risk for thro
[Practical aspects of therapy with new oral anticoagulants in patients with impaired renal function]
Autor:
Kropacheva Es
Publikováno v:
Kardiologiia. 54(4)
The article deals with renal dysfunction, methods of assessment and monitoring in patients receiving anticoagulant therapy. Due to the negative impact of renal impairment on the incidence of thromboembolic and hemorrhagic complications in patients wi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.